Alleviant ALLAY-HF Study

a study on Heart Failure

Summary

Eligibility
for people ages 40 years and up (full criteria)
Location
at UC Davis UCSF
Dates
study started
study ends around
Principal Investigator
by Tai Pham, MD (ucdavis)Richard Cheng, MD (ucsf)

Description

Summary

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.

Official Title

Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients With Chronic Heart Failure

Keywords

Heart Failure, Alleviant ALV1 System

Eligibility

You can join if…

Open to people ages 40 years and up

  1. Symptomatic HFpEF/HFmrEF with LVEF greater than or equal to 40%
  2. NYHA Class II, III or ambulatory IV
  3. Exercise right heart catheterization*
    1. Elevated left atrial pressure during exercise right heart catheterization (greater than or equal to 25 mmHg)
    2. Exercise PVR < 1.8 WU
  4. Ongoing stable GDMT

You CAN'T join if...

  1. Advanced heart failure
  2. Presence of a pacemaker
  3. Evidence of right heart dysfunction

Locations

  • UC Davis Medical Center accepting new patients
    Sacramento California 95817 United States
  • University of California San Francisco accepting new patients
    San Francisco California 94143 United States
  • Scripps Clinical Research Services accepting new patients
    San Diego California 92121 United States
  • Memorial Care Long Beach Medical Center accepting new patients
    Long Beach California 90806 United States

Lead Scientists at University of California Health

  • Tai Pham, MD (ucdavis)
    Assistant Professor of Clinical, MED: Int Med Cardiology (Sac), School of Medicine. Authored (or co-authored) 6 research publications
  • Richard Cheng, MD (ucsf)

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Alleviant Medical, Inc.
ID
NCT05685303
Study Type
Interventional
Participants
Expecting 700 study participants
Last Updated
Contact us about this trial